Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression by Avadhanula, Vasanthi et al.
INFECTION AND IMMUNITY, Feb. 2006, p. 830–838 Vol. 74, No. 2
0019-9567/06/$08.000 doi:10.1128/IAI.74.2.830–838.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Nontypeable Haemophilus influenzae Adheres to Intercellular Adhesion
Molecule 1 (ICAM-1) on Respiratory Epithelial Cells and
Upregulates ICAM-1 Expression
Vasanthi Avadhanula,1,2 Carina A. Rodriguez,1 Glen C. Ulett,1 Lauren O. Bakaletz,4
and Elisabeth E. Adderson1,2,3*
Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee1; Departments of Molecular
Sciences2 and Pediatrics,3 University of Tennessee Health Sciences Center, Memphis, Tennessee; and
Columbus Children’s Research Institute and The Ohio State University, Columbus, Ohio4
Received 16 August 2005/Returned for modification 13 October 2005/Accepted 5 November 2005
Nontypeable Haemophilus influenzae (NTHI) is an important respiratory pathogen. NTHI initiates infection
by adhering to the airway epithelium. Here, we report that NTHI interacts with intracellular adhesion molecule
1 (ICAM-1) expressed by respiratory epithelial cells. A fourfold-higher number of NTHI bacteria adhered to
Chinese hamster ovary (CHO) cells transfected with human ICAM-1 (CHO-ICAM-1) than to control CHO
cells (P < 0.005). Blocking cell surface ICAM-1 with specific antibody reduced the adhesion of NTHI to A549
respiratory epithelial cells by 37% (P  0.001) and to CHO-ICAM-1 cells by 69% (P  0.005). Preincubating
the bacteria with recombinant ICAM-1 reduced adhesion by 69% (P  0.003). The adherence to CHO-ICAM-1
cells of NTHI strains deficient in the adhesins P5, P2, HMW1/2, and Hap or expressing a truncated lipooli-
gosaccharide was compared to that of parental strains. Only strain 1128f, which lacks the outer membrane
protein (OMP) P5-homologous adhesin (P5 fimbriae), adhered less well than its parental strain. The numbers
of NTHI cells adhering to CHO-ICAM-1 cells were reduced by 67% (P  0.009) following preincubation with
anti-P5 antisera. Furthermore, recombinant ICAM bound to an OMP preparation from strain 1128f, which
expresses P5, but not to that from its P5-deficient mutant, confirming a specific interaction between ICAM-1
and P5 fimbriae. Incubation of respiratory epithelial cells with NTHI increased ICAM-1 expression fourfold
(P  0.001). Adhesion of NTHI to the respiratory epithelium, therefore, upregulates the expression of its own
receptor. Blocking interactions between NTHI P5 fimbriae and ICAM-1 may reduce respiratory colonization by
NTHI and limit the frequency and severity of NTHI infection.
Nontypeable Haemophilus influenzae (NTHI) is a gram-neg-
ative nonencapsulated coccobacillus. It is the most frequent
cause of bacterial exacerbations of chronic obstructive pulmo-
nary disease; a major cause of acute otitis media, sinusitis, and
bronchitis; and an occasional cause of serious invasive infec-
tions, such as bacteremia and meningitis. Adhesion of NTHI to
the respiratory epithelium promotes colonization and subse-
quent epithelial and endothelial invasion by the bacteria.
NTHI binds specifically to a variety of receptors on the host
cell membrane, including carcinoembryonic antigen cell adhe-
sion molecule 1 (CEACAM1) and CEACAM3, platelet-acti-
vating factor receptor, fibronectin, laminin, and respiratory
epithelial mucins (10, 14, 18, 31, 42). The importance of NTHI
interaction with each of these receptors during human coloni-
zation and infection, however, is not yet well understood.
Intercellular adhesion molecule 1 (ICAM-1; CD54) is a
member of the immunoglobulin (Ig)-like superfamily that con-
tains five Ig domains, a transmembrane domain, and a short
cytoplasmic tail (30). ICAM-1 makes possible reversible adhe-
sion and signal transduction between cells, processes critical to
normal leukocyte recruitment and to T-cell development, by
interacting with specific receptors. As is the case with other
eukaryotic receptor molecules, the expression of ICAM-1 by a
variety of human cells has been subverted by pathogens to
facilitate their own adhesion and uptake. ICAM-1 serves as a
receptor for the majority (90%) of human rhinoviruses; is
required for cell entry by coxsackieviruses; and, in concert with
CD36, it mediates the adherence of Plasmodium falciparum-
infected erythrocytes to endothelial cells (21, 33, 41). Here, we
demonstrate that NTHI also adheres to human respiratory
epithelium by binding specifically to ICAM-1 and that the
NTHI ligand for ICAM-1 is P5 fimbria, a major outer
membrane protein that also binds respiratory mucin and
CEACAM1 (14, 28).
MATERIALS AND METHODS
Bacterial culture. Most assays were performed with NTHI strain 778. This
clinical isolate expresses Hap, high-molecular-weight 1 and 2 adhesins (HMW1/
HMW2), pili (Hif), P5 fimbriae, and phosphorylcholine (data not shown) (1, 26,
36, 38). NTHI strains 781 (hap hmw hia/hif negative) and Rd, which also
express P5 fimbriae (data not shown), were also tested. Wild-type NTHI strain
1128f and its isogenic P5 fimbrial mutant, 1128f, have been previously de-
scribed (34). NTHI strain 12 (hmw1/hmw2 positive; hia/hif negative) and its
isogenic mutant lacking hmw1/hmw2 (37), N187 (hmw1/hmw2 and hap positive),
N187 Hap (an isogenic mutant of N187 lacking hap), N187 HapHMW (an
isogenic mutant of N187 lacking both hap and hmw1/hmw2) (13), Rd, and Rd
lacking outer membrane protein P2 were provided by J. St Geme III, Washington
University School of Medicine. NTHI strains 2019 (wild type) and 2019
pgmB::erm, which expresses a truncated LOS lacking branch oligosaccharides
(42), were provided by M. Apicella, University of Iowa. NTHI was grown in brain
heart infusion broth (Difco, Sparks, MD) supplemented with 10 g/ml hemin
(Sigma, St. Louis, MO) and 1 g/ml of -NAD (Sigma) (sBHI) or on sBHI or
chocolate II agar (Edge Biologics, Memphis, TN) at 37°C in 5% CO2.
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S. pneumoniae strain 357 is an encapsulated strain isolated from the nasophar-
ynx of a child and was provided by E. Tuomanen, St. Jude Children’s Research
Hospital. It was grown on tryptic soy agar (Difco) with 3% defibrinated sheep’s
blood (Enova Medical Technologies, St. Paul, MN), or in CY medium at 30°C
and 5% CO2 (19).
Cell culture. A549 respiratory epithelial cells (CCL-185; American Type Cul-
ture Collection [ATCC], Manassas, VA) and Chinese hamster ovary (CHO) cells
(CRL-9618; ATCC) were cultivated in Hams F-12K medium (ATCC) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS). CHO cells stably
transfected with human ICAM-1 (CHO-ICAM-1) (CRL-2093; ATCC) were
maintained in RPMI 1640 (ATCC) supplemented with 10% FBS.
Bacterial-adhesion assays. Bacteria were grown overnight in broth, diluted
1:10 in fresh medium, and grown to log phase for adhesion assays. Prior to the
assays, the bacteria were washed three times in phosphate-buffered saline (PBS)
and resuspended in tissue culture medium. Bacterial concentrations were deter-
mined by optical density at 600 nm, and the numbers of bacteria were retrospec-
tively confirmed by plating serial dilutions of the starting inocula. A549 or CHO
cells were grown to confluence in 24-well plates (Costar; Corning Inc., Corning,
NY). The cell monolayers were washed twice with PBS, and then triplicate wells
were incubated with bacteria at a multiplicity of infection (MOI) of two bacteria
per eukaryotic cell for 1 h at 37°C in 5% CO2. The cells were then washed three
times with PBS to remove loosely adherent bacteria, detached from the plates by
incubation for 10 min at 37°C with 1 trypsin-EDTA (Mediatech Inc., Herndon,
VA), and washed twice with PBS, and serial dilutions were plated for quantifi-
cation of adherent bacteria. For each assay, the numbers of bacteria were nor-
malized to the numbers of epithelial cells.
Confocal microscopy. NTHI 778 and Streptococcus pneumoniae (5 107 CFU)
were incubated with fluorescein isothiocyanate (FITC) solution (1 mg/ml FITC
in carbonate buffer containing 0.1 M NaCl, 0.09 M Na2CO3, and 0.015 M
NaHCO3, pH 9.2 [Sigma]) for 30 min, washed twice with PBS, and resuspended
in cell culture medium. CHO and CHO-ICAM-1 cells were grown to confluence
in LAB-TEK glass chamber slides (Nalge Nunc International, Naperville, IL).
The cells were inoculated with FITC-labeled bacteria at an MOI of 100 as
described above. A larger inoculum of bacteria was used in these studies than in
adhesion assays to more readily visualize adherent bacteria. The cells were then
washed, fixed with 4% paraformaldehyde (Sigma) for 10 min at room tempera-
ture, and rinsed. After being blocked with 4% normal goat serum (Sigma), 0.5%
bovine serum albumin, and 1% Triton X-100 in PBS, the cells were rinsed with
PBS and incubated with a 1/250 dilution of anti-ICAM-1 antibody (Ab) (BD
Biosciences) in blocking buffer for 1 h at 37°C and then incubated with a 1/500
dilution of Alexa 594-conjugated goat anti-mouse secondary antibody (Ab) (Mo-
lecular Probes, Eugene, OR) in blocking buffer for 1 h at 37°C. After thorough
rinsing with PBS, the cells were mounted with the DNA-specific dye TO-PRO-3
(Molecular Probes). The cells were examined with a Leica TCS NT SP confocal
laser scanning microscope equipped with argon (488-nm) and helium-neon (633-
nm) lasers.
Inhibition of ICAM-1-mediated adhesion of NTHI to epithelial cells. The
ability of NTHI to adhere to A549 and CHO-ICAM-1 cells was compared to its
ability to bind to cells on which cell surface ICAM-1 was blocked by preincuba-
tion with purified mouse anti-human CD54/ICAM-1 monoclonal antibodies
(MAbs): clone LB2, IgG2b (BD Biosciences, San Jose, CA), and clone R1/1,
IgG1, and clone 8.4A6, IgG1 (Alexis Biochemicals, San Diego, CA). Epithelial
cell monolayers were incubated with 0 to 20 g/ml of anti-ICAM-1 or control
mouse IgG2b or IgG1 Ab (BD Biosciences) in cell culture medium for 1 h at
37°C in 5% CO2. The cells were then rinsed with PBS and inoculated with NTHI,
and the numbers of adherent bacteria were quantified as previously described.
The ability of NTHI to adhere to respiratory epithelial cells was also deter-
mined after the bacterial surface ligands that bind to the ICAM-1 receptor were
blocked using recombinant ICAM-1 (rICAM-1; R&D Systems, Minneapolis,
MN). Bacteria were incubated with 0 to 4 g/ml of rICAM-1 for 2 h at 37°C in
RPMI 1640 without FBS (to prevent bacterial replication) and used in adhesion
assays as previously described.
Inhibition of P5-mediated NTHI adhesion to ICAM-1 cells. The specificity of
NTHI P5 fimbrial binding to ICAM-1 on respiratory epithelial cells was tested by
comparing binding to CHO-ICAM-1 cells by untreated bacteria to that of bac-
teria in which fimbrial binding was blocked by preincubation with anti-P5 anti-
serum. Bacteria were incubated with a 1:200 to 1:1,000 dilution of rabbit poly-
clonal anti-P5 antiserum (23) or control preimmune rabbit serum for 1 h at 37°C
in RPMI 1640 without FBS, and adhesion assays were performed as described
above.
P5 binding by rICAM-1. Whole outer membrane proteins (OMPs) of NTHI
strains 112f (P5) and 1128f (P5) and peptides corresponding to the four
predicted surface-exposed loops of P5 were prepared as described previously (24,
34). Proteins, peptides, and rICAM-1 (10 g; R&D Systems) were spotted on a
nitrocellulose membrane using a 96-well vacuum apparatus (Bio-Rad, Hercules,
CA). The membrane was blocked with 5% nonfat dry milk in PBS for 1 h,
washed, and incubated with 5 g/ml of rICAM-1 in 5% nonfat dry milk in PBS
for 1 h, followed by mouse anti-human ICAM-1 monoclonal Ab (BD Bio-
sciences) at a 1:1,000 dilution for 1 h. Bound Ab was detected using peroxidase-
conjugated goat anti-mouse secondary Ab (ECL Western Blotting Analysis Sys-
tem; Amersham Biosciences, Piscataway, NJ).
Flow-cytometric analysis of ICAM-1 expression. A549 cells were propagated
in 12-well plates and infected with NTHI at an MOI of 1, 10, or 100 as previously
described. After 6 h of incubation, the cells were washed and detached from the
plates by incubation with 500 l/well cell dissociation solution and washed with
PBS, and 106 cells were resuspended in 1 ml of 1% bovine serum albumin-PBS.
The cells were then incubated with a 1/1,000 dilution of mouse anti-human
CD54–ICAM-1 (IgG1; BD Biosciences) or purified mouse IgG1 Ab (BD Bio-
sciences) (an isotype control) for 1 h at 25°C. The cells were washed once with
PBS and then incubated with a 1/500 dilution of FITC-labeled goat anti-mouse
Ab (BD Biosciences) for 30 min at 4°C in the dark and washed, and 104 cells were
analyzed by flow cytometry. The mean fluorescence intensity of the cells was
compared to that of uninfected cells after background staining produced by
isotype control Abs was subtracted.
Statistical analysis. Data are expressed as the mean  standard error. Com-
parison between groups was performed using the Mann-Whitney U test, and
other data were analyzed by Student’s t test, with P values of 0.05 considered
significant.
RESULTS
NTHI binding to respiratory epithelial cells is reduced by
monoclonal anti-ICAM-1 antibody. Previous work by ourselves
and other investigators determined that NTHI is able to ad-
here to epithelial cells using a variety of cell surface ligands,
including respiratory mucin, CEACAM1 and -3, platelet-acti-
vating factor receptor, fibronectin, and laminin (10, 14, 18, 31,
42). In preliminary studies, efforts to completely prevent NTHI
from adhering to the respiratory epithelium by blocking inter-
actions with these receptors were not successful (data not
shown), suggesting that another, as-yet-unidentified NTHI re-
ceptor might exist on these cells. Several important human
pathogens adhere to and invade host cells using the immuno-
globulin-like molecule ICAM-1. We therefore hypothesized
that ICAM-1 might also be a ligand for NTHI. Blocking
FIG. 1. Adhesion of NTHI to A549 respiratory epithelial cells is
blocked by anti-ICAM-1 antibodies. A549 cells were incubated with
anti-ICAM-1 Ab or an isotype control (15 g/ml) for 1 h, infected with
NTHI for 1 h, and washed to remove loosely adherent bacteria. Ad-
herent bacteria were quantified by plating serial dilutions of A549 cell
lysates on agar. Preincubation of A549 cells with anti-ICAM-1 Ab
(black bar) significantly reduced the adhesion of NTHI compared to
preincubation with an isotype control Ab (white bar) (, P  0.001).
Adhesion is expressed as the number of bacteria/cell. The data repre-
sent the mean  standard error of the mean of four separate experi-
ments.
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ICAM-1 by preincubating A549 cells with anti-ICAM-1 anti-
body reduced the numbers of adherent bacteria by 37% (P 
0.001), suggesting that this was the case. The adhesion of
NTHI to A549 cells was reduced from 0.25  0.02 bacterium
per cell (12.5% of the inoculum) when incubated with isotype
control antibody to 0.16  0.01 bacterium per cell (8% of the
inoculum) (P  0.001) when incubated with anti-ICAM-1 an-
tibody (Fig. 1).
NTHI binds to CHO cells transfected with ICAM-1. The
ability of anti-ICAM-1 antibody to block NTHI adhesion to
respiratory epithelial cells suggested that ICAM-1 itself might
serve as a ligand for the bacteria. Interpretation of these as-
says, however, is complicated by the presence of multiple re-
ceptors for NTHI on A549 cells. Additionally, the expression
of some of these receptors may be up- or downregulated,
depending on experimental conditions (7, 22, 44, 45). The
adhesion of NTHI to CHO cells stably transfected with human
ICAM-1 was studied to clarify this interaction.
Adhesion of NTHI 778 was tested at MOIs of 2, 20, and 200.
The number of bacteria adhering to CHO-ICAM-1 increased
with the increase in the inoculum. At an MOI of 2, 0.07 
0.011 bacterium per cell (3.9% of the inoculum) adhered to
CHO-ICAM-1 cells compared to 4.2  0.04 bacteria per cell
(21% of the inoculum) at an MOI of 20 and 58  1.2 bacteria
per cell (29% of the inoculum) at an MOI of 200. In contrast,
the numbers of NTHI cells binding to nontransfected CHO
cells did not differ significantly with an increase in the inocu-
lum (data not shown). An MOI of 2 was used for subsequent
studies.
Adhesion of H. influenzae strains 778, 781, and Rd to non-
transfected CHO cells was low: 0.018  0.008 bacterium ad-
hered per cell (0.9% of the inoculum) for 778, 0.025  0.006
bacterium adhered per cell (1.2% of the inoculum) for 781,
and 0.021  0.005 bacterium adhered per cell (1.06% of the
inoculum) for Rd. The adherence of NTHI strains 778, 781,
and Rd to CHO-ICAM-1 cells was increased by 4-, 5-, and
4.5-fold, respectively, compared to untransfected CHO cells.
The adherence of 778 increased to 0.064  0.002 bacterium
per cell (3.2% of the inoculum) (P  0.001), that of 781
increased to 0.101  0.006 bacterium per cell (5% of the
inoculum) (P  0.001), and that of Rd increased to 0.091 
0.006 bacterium per cell (4.5% of the inoculum) (P  0.005)
(Fig. 2A). In contrast, the numbers of S. pneumoniae cells
adhering to CHO cells and to CHO-ICAM-1 cells did not
differ significantly; 0.019  0.001 bacterium per cell (0.95% of
the inoculum) bound to CHO cells, while 0.022  0.001 bac-
terium per cell (1.1% of the inoculum) bound to CHO-
ICAM-1 cells. These differences were confirmed by confocal
microscopy of eukaryotic cells incubated with FITC-labeled
NTHI 778 and pneumococci (Fig. 2B). These data suggest that
NTHI cells, but not pneumococci, bind to human ICAM-1.
Anti-ICAM-1 antibodies and rICAM-1 reduce the adhesion
of NTHI to CHO- ICAM-1 cells. CHO-ICAM-1 monolayers
were preincubated with anti-ICAM-1 antibodies to determine
the specificity of NTHI binding to ICAM-1. Adhesion of NTHI
to CHO-ICAM-1 cells was inhibited in a dose-dependent man-
ner with increasing concentrations of antibody. Adhesion of
NTHI 778 was reduced from 0.064  0.002 bacterium per cell
(3.25% of the inoculum) following preincubation with 0 g/ml
anti-ICAM-1 MAb (clone LB2) to 0.020 0.001 bacterium per
cell (1% of the inoculum) following preincubation with 20
g/ml of anti-ICAM-1 MAb (P  0.005) (Fig. 3A). Adhesion
of strains 781 and Rd also decreased by 64% and 70%, respec-
tively, following incubation with 20 g/ml anti-ICAM-1 anti-
body (data not shown). In contrast, NTHI adhesion was not
affected by preincubation with an irrelevant isotype control
antibody.
ICAM-1 is composed of five tandemly linked extracellular
domains, designated D1 to D5. The binding site of the physi-
ological ligand of ICAM-1, LFA-1, is located in D1 (39). D2
also plays an important role in the conformation of D1. Since
the anti-ICAM-1 MAb used in the above-mentioned experi-
ments, clone LB2, has been reported to block the interaction of
LFA-1 with ICAM-1 (20), this suggested that NTHI also binds
to D1 or D2. Two additional antibodies, R1/1 and 8.4A6, that
block the interaction of LFA-1 with ICAM-1 by binding to D1
and D2, respectively, were tested to investigate if preincuba-
tion of CHO-ICAM-1 cells with these antibodies would inter-
fere with NTHI adherence. The numbers of adherent NTHI
cells decreased from 0.064  0.002 bacterium per cell (3.25%
of the inoculum) to 0.055  0.004 (2.75% of the inoculum)
(P  0.03) and 0.045  0.009 (2.25% of the inoculum) (P 
0.01) bacterium per cell after incubation with 10 g/ml of the
anti-ICAM-1 antibodies clones R1/1 and 8.4A6, respectively
(Fig. 3B). R1/1 and 8.4A6 did not inhibit the adhesion of NTHI
as well as LB2, even at high concentrations. These data suggest
that NTHI may bind at a site adjacent to the D1 and D2
junction or overlapping these domains.
The adhesion of NTHI to CHO-ICAM-1 cells was also re-
duced in a dose-dependent fashion by preincubation of bacte-
ria with rICAM-1. The adhesion of NTHI was reduced from
0.075  0.005 bacterium per cell (3.75% of the inoculum)
following preincubation with 0 g/ml rICAM-1 to 0.023 
0.004 bacterium per cell (1.15% of the inoculum) following
preincubation with 4 g/ml rICAM-1 (69% reduction; P 
0.003) (Fig. 3C). The adhesion of strains 781 and Rd decreased
by 68% and 73%, respectively, following incubation with 4
FIG. 2. Adhesion of NTHI and S. pneumoniae to CHO and CHO-ICAM-1 cells. CHO and CHO-ICAM-1 cells were incubated with H.
influenzae strain 778, 781, or Rd or S. pneumoniae for 1 h and washed to remove loosely adherent bacteria. Adherent bacteria were quantified by
plating serial dilutions of cell lysates on agar plates. Adhesion is expressed as numbers of bacteria/cell. (A) More NTHI cells adhered to
CHO-ICAM-1 cells (black bars) than to control CHO cells (white bars) (, P  0.005), whereas there was no significant difference in the adhesion
of S. pneumoniae to CHO or CHO-ICAM-1 cells. The data represent the mean  standard error of the mean of four separate experiments.
(B) CHO-ICAM-1 cells were incubated with FITC-labeled NTHI or S. pneumoniae for 1 h, stained with anti-ICAM-1 antibody, and then washed
and incubated with Alexa 594-conjugated anti-IgG secondary antibody and the double-stranded DNA specific fluorochrome To-PRO3. (Top)
FITC-labeled NTHI (green) binds primarily to cells expressing ICAM-1 (red). Cell nuclei are counterstained blue. (Bottom) Few FITC-labeled
S. pneumoniae cells (green) adhere to CHO-ICAM-1 cells.
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g/ml rICAM-1 (data not shown). Together, these data sug-
gest that NTHI specifically binds human ICAM-1.
P5 fimbriae mediate binding to ICAM-1. NTHI expresses
five well-characterized adhesins: LOS, HMW1/2, Hap, P2, and
P5. We compared the adherence of mutant NTHI strains lack-
ing each of these structures and their parental strains to CHO-
ICAM-1 cells to determine if any of these structures might
confer the ability to bind ICAM-1. Of the NTHI strains tested,
only strain 1128f, which lacks P5 fimbriae, adhered less well
to CHO-ICAM-1 cells than its parent strain. Only 0.015 
0.007 (0.75% of the inoculum) P5-deficient bacterium adhered
per CHO-ICAM-1 cell compared to 0.043  0.007 (2.15% of
the inoculum) wild-type bacterium (a reduction of 65%; P 
0.003) (Fig. 4).
NTHI 778 was preincubated with anti-P5 polyclonal rabbit
antiserum (or control preimmune rabbit serum) to determine
if blocking P5 on the bacterial surface interfered with binding
to ICAM-1. The adhesion of NTHI was reduced in a dose-
dependent manner with increasing concentrations of anti-P5
antisera but not with control preimmune serum. Binding of
NTHI was reduced by 67%, from 0.071  0.008 bacterium per
cell (3.6% of the inoculum) to 0.025  0.0009 bacterium per
cell (1.25% of the inoculum) (P  0.009), following preincu-
bation with a 1:200 dilution of anti-P5 antiserum (Fig. 5).
FIG. 3. Blocking with anti-ICAM-1 antibodies and rICAM-1 reduces NTHI adhesion to CHO-ICAM-1 cells. CHO-ICAM-1 cells were
incubated with anti-ICAM-1 MAb at the indicated concentrations (in g/ml). The cells were then infected with NTHI, and the numbers of bacteria
adhering to the cells were compared to the numbers of bacteria binding to untreated cells. (A) Treatment with anti-ICAM-1 MAb (LB2) resulted
in a dose-dependent inhibition of NTHI adhesion. The data represent the mean  standard error of five independent experiments (, P  0.005).
Preincubation of CHO-ICAM-1 cells with an isotype control antibody did not alter NTHI adherence (data not shown). (B) Adhesion of NTHI was
also determined after incubating CHO-ICAM-1 cells with MAbs R1/1 and 8.4A6, which bind ICAM-1 D1 and D2, respectively. Both R1/1 and
8.4A6 at concentrations of 10 g/ml reduced the numbers of adherent NTHI cells (, P  0.03 for R1/1 and P  0.01 for 8.4A6). In contrast,
preincubation of CHO-ICAM-1 cells with isotype control antibodies did not alter NTHI adherence (data not shown). The data represent the mean
 standard error of four independent experiments. (C) NTHI was preincubated with rICAM-1 at the indicated concentrations and then used to
infect CHO-ICAM-1 cells. Preincubation of bacteria with rICAM-1 resulted in a dose-dependent inhibition of NTHI adhesion to ICAM-1 cells
(, P  0.003). The data represent the mean  standard error of five independent experiments.
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NTHI was incubated with medium alone or with a 1:200 dilu-
tion of control preimmune serum or anti-P5 antiserum for 1 h
to determine if nonspecific agglutination might give the ap-
pearance of reduced binding to ICAM-1 cells. Serial dilutions
of bacteria were then plated on agar plates. There was no
reduction in the number of bacteria treated with control pre-
immune serum or anti-P5 antiserum compared to medium
alone, suggesting that decreased adhesion is more likely to be
attributable to blocking of ICAM-1–P5 fimbrial interactions
(data not shown).
The ability of rICAM-1 to bind directly to outer-membrane
preparations of NTHI and to peptides corresponding to pre-
dicted surface-exposed regions of P5 fimbriae of NTHI strain
1128 (24) was also determined. rICAM-1 bound to OMPs from
NTHI 1128f (P5 sufficient) but not to 1128f (P5 deficient).
ICAM-1 also bound specifically to P5 peptide 4, suggesting
that this region may be involved in the interaction with
ICAM-1 (Fig. 6).
NTHI stimulates the expression of ICAM-1 on A549 cells.
Incubation of respiratory epithelial cells with NTHI was pre-
viously reported to upregulate the expression of ICAM-1 and
thus has the potential to increase inflammatory responses to
infection (11). To confirm this observation, the expression level
of ICAM-1 was measured following incubation with NTHI-778
using fluorescence-activated cell sorter analysis. Incubation of
NTHI with A549 cells increased the expression of ICAM-1 in
an inoculum-dependent manner, with an MOI of 10 resulting
in a threefold increase (P  0.01) in ICAM-1 expression and
an MOI of 100 resulting in a fourfold increase (P  0.001)
(Fig. 7). Thus, adhesion of NTHI to the respiratory epithelium
upregulates the expression of its own receptor, ICAM-1, in an
inoculum-dependent fashion.
FIG. 4. An isogenic mutant strain of NTHI lacking P5 adheres poorly to CHO-ICAM-1 cells compared to its P5-sufficient parental strain.
CHO-ICAM-1 cells were incubated with NTHI strains and their isogenic mutants lacking HMW1 and HMW2 (strain 12, HMW); HMW1,
HMW2, and Hap proteins (strain N187, HMW, and N187, Hap); P2 fimbriae (strain Rd, P2); and P5 fimbriae (strain 1128f) and expressing
LOS (strain 2019) or truncated LOS (strain 2019, pgmB::erm), and adherent bacteria were quantified. Only the P5 fimbria-deficient strain 1128f
had significant reduction in adhesion to CHO-ICAM-1 cells compared to its parental strain (, P 0.003). The data represent the mean  standard
error of five independent experiments.
FIG. 5. Incubation with anti-P5 antibodies inhibits adhesion of NTHI 778 to ICAM-1 cells. NTHI 778 was preincubated with increasing
concentrations of rabbit anti-P5 antiserum (black bars) or control preimmune serum (white bars) at the indicated concentrations and then
incubated with CHO-ICAM-1 cells. Preincubation of bacteria with anti-P5 Ab resulted in a dose-dependent inhibition of NTHI adhesion to
CHO-ICAM-1 cells. The data represent the mean  standard error of four independent experiments (, P  0.009).
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DISCUSSION
The adherence of NTHI to respiratory epithelial cells allows
the bacteria to overcome many of the body’s physical barriers
to infection. Most infections caused by NTHI are preceded by
bacterial colonization of the respiratory epithelium, and the
likelihood of symptomatic disease appears to increase with an
increase in the extent of colonization (27, 32). The success of
NTHI as a human pathogen may be, in part, attributable to its
ability to adhere to a diverse group of host cell molecules. Pili
and the major outer membrane P2 protein bind sialic acid-
containing moieties on epithelial cell surfaces (18, 28). In the
latter instance, sialic acid-containing oligosaccharides of respi-
ratory epithelial mucin appear to be most important for bac-
terial adhesion. The phosphorylcholine residue of NTHI LOS
interacts with platelet-activating factor receptor to enhance
respiratory epithelial cell adherence and invasion (42). NTHI
Hap promotes bacterial adhesion to epithelial cells and micro-
colony formation by binding eukaryotic fibronectin, laminin,
and collagen IV (10), and finally, P5 fimbriae specifically bind
to host CEACAM1 (14). In the current study, we show that
NTHI also adheres to respiratory epithelial cells by directly
binding ICAM-1, and P5 fimbriae mediate this interaction.
ICAM-1 is a member of the immunoglobulin superfamily, a
type I transmembrane glycoprotein with an extracellular region
comprised of five tandemly repeated immunoglobulin con-
stant-region-like domains (40). Its major physiologic function
is to promote cell adhesion during inflammation and immune
responses. Physiological ligands of ICAM-1 include the alpha-
beta integrin receptors, leukocyte-associated function antigen
1 (LFA-1; CD11a/CD18), and macrophage 1 antigen (Mac-1;
C3; CD11b/CD18), CD43, fibrinogen, and hyaluronan (15, 35).
Expression of ICAM-1 by CD8 T cells facilitates interactions
between the T-cell receptor and major histocompatibility class
I and II peptides (43). The expression of ICAM-1 on epithelial
and endothelial cells directs the trafficking of leukocytes from
the circulation to sites of inflammation by stabilizing the initial,
weaker interactions of leukocytes with other selectin molecules
(4).
ICAM-1 also contributes to innate immune responses to
bacterial pathogens by promoting the uptake of bacterial
pathogens by macrophages and increases neutrophil recruit-
ment in the lung (16, 25). Frick and coworkers and Humlicek
et al. found that adherence of NTHI to respiratory epithelial
cells rapidly induced ICAM-1 expression, a process they hy-
pothesized would facilitate the recruitment of neutrophils to
sites of NTHI infection (11, 16). Although advantageous to the
human host, this process is likely to adversely affect NTHI and
other bacterial pathogens by increasing the numbers of phago-
cytes at sites of colonization. The ability of NTHI to bind to
ICAM-1 may, to some degree, compensate for the disadvan-
tages of increased ICAM-1 expression by increasing the num-
bers of adherent bacteria. This strategy would be particularly
useful if NTHI binding to ICAM-1 blocked subsequent leuko-
cyte adhesion to ICAM-1.
In contrast to other integrin receptors, ICAM-1 does not
possess an Arg-Gly-Asp (RGD) binding motif. The binding
site on ICAM-1 for Mac-1 is located on the third NH2-terminal
immunoglobulin-like domain (8), whereas the binding sites for
LFA-1, human picornaviruses, Plasmodium-infected erythro-
cytes, and fibronectin are located on overlapping but noniden-
tical segments of the most amino-terminal D1 and D2 do-
mains, which are most distant from the host cell surface (2, 49).
Our data suggest that NTHI shares this binding site. The LB2,
R1/1, and 8.4A6 MAbs all block the interaction of LFA-1 with
ICAM-1, although each binds to a distinct ICAM-1 epitope
(3).
The P5 fimbrin is an important virulence factor in a chin-
chilla model of otitis media (34). P5 has been previously re-
ported to bind to both respiratory mucin and CEACAM1 (14,
28). Our data indicate that it also binds ICAM-1, and there-
fore, like another important NTHI adhesin, Hap, P5 is able to
interact with a very diverse group of eukaryotic cell surface
molecules (10). Antibodies directed against P5 are protective
in rat and chinchilla models of middle-ear infection; however,
during chronic infections with NTHI, the protein is antigeni-
cally variable, potentially permitting bacteria to evade immune
recognition and killing (9, 12, 23). Determining whether the
antigenic variability of P5 proteins is significant in normal
FIG. 6. rICAM binds to outer membrane protein P5. Whole OMPs
of NTHI 1128f (lane 1) and 1128f (lane 2); peptides 1 to 4 (lanes 3
to 6), corresponding to the four predicted surface-exposed regions of
P5; and rICAM-1 (positive control) (lane 7) were spotted on a nitro-
cellulose membrane and incubated with rICAM-1. Anti-ICAM-1 Ab
was used to detect bound ICAM-1. rICAM-1 binds to OMP prepara-
tions from P5-sufficient strain 1128f, but not P5-deficient strain
1128f, and to a peptide corresponding to loop 4 of P5 fimbriae.
FIG. 7. NTHI infection increases ICAM-1 expression on A549
cells. A549 cells were infected by NTHI 778 at an MOI of 1, 10, or 100
for 6 h, and ICAM-1 expression was quantified by fluorescence-acti-
vated cell sorting. The histograms illustrate the fluorescence intensity
(ICAM-1 expression; horizontal axis) of uninfected control cells (dot-
ted line) compared to that of cells infected with increasing numbers of
NTHI. The expression level of A549 cell ICAM-1 increased in an
inoculum-dependent manner by threefold at an MOI of 10 (gray line)
(P  0.01) and by fourfold at an MOI of 100 (black line) (P  0.001).
The data are representative of three independent experiments.
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human infections will require further study. The ability of P5
and other important NTHI adhesins to bind to a number of
eukaryotic receptors, however, is likely to contribute to the
organism’s ability to colonize and infect humans.
ICAM-1 is expressed constitutively on a wide variety of cells,
generally at a low basal level. Its expression is transcriptionally
regulated through one of four pathways: NF-	B, gamma inter-
feron–Janus kinase/signal transduction-activating transcription
(JAK/STAT), mitogen-activated protein (MAP) kinase/activa-
tor protein 1 (AP1), and, indirectly, protein kinase C (PKC)
(29). NTHI infection of tracheal epithelial cells induces the
secretion of a number of proinflammatory cytokines, including
tumor necrosis factor alpha, monocyte chemoattractant pro-
tein 1 (MCP-1), interleukin 6, and interleukin 8 (5). Addition-
ally, NTHI and tumor necrosis factor alpha synergistically in-
duce NF-	B activation through NF-	B-inducing kinase–I	B
kinase 
/-dependent phosphorylation and ubiquitination of
I	B and by the MEKK1-dependent activation of the p-38
MAP kinase kinase (MKK3/6) MAPK pathway (48). It there-
fore seems probable that NF-	B pathway activation is respon-
sible for the NTHI-stimulated upregulation of ICAM-1 expres-
sion on respiratory epithelial cells (6, 17, 46, 47). Further
studies, however, are needed to confirm this hypothesis and to
identify what other positive regulatory pathways, if any, may be
initiated by NTHI.
The ability of NTHI to upregulate ICAM-1 expression on
respiratory cells is reduced by inhibiting protein synthesis with
chloramphenicol or by killing bacteria with gentamicin. Sterile
filtered NTHI culture supernatants also failed to increase
ICAM-1 expression (11). These data imply that the factor
responsible for the induction of ICAM-1 expression is a con-
stitutive, cell surface-expressed molecule. In other studies, in-
cubation of epithelial cells with purified H. influenzae lipooli-
gosaccharide did not increase ICAM-1 expression, and both
wild-type and mutant NTHI strains lacking HMW1, HMW2,
or Hap had equivalent capacities to induce ICAM-1 expression
on A549 cells. It is therefore tempting to hypothesize that
NTHI both adheres to epithelial cells and stimulates ICAM-1
expression by interactions with the same receptor, P5; how-
ever, further studies will be required to address this issue.
In summary, we report that NTHI binds to respiratory epi-
thelial cells by binding of P5 fimbriae to ICAM-1. The NTHI
ICAM-1 binding site appears to be identical or closely related
to the binding sites of LFA-1, human rhinoviruses, and cox-
sackieviruses. Our studies confirm that adherence of NTHI to
epithelial cells increases ICAM-1 expression by respiratory
epithelial cells. Thus, NTHI is able to positively regulate the
expression of its own cell surface receptor. Blocking P5–
ICAM-1 interactions has the potential to modify bacterial ad-
herence and inflammatory responses to infection and to reduce
the risk or severity of disease.
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